The nation has the academic know-how, but lacks a market strategy and solid supply chain to boost the biotech sector at home and make inroads in the global market, the Cabinet’s biotechnology committee said yesterday.
The committee, responsible for making biotechnology the next mainstream industry in a decade, said in a report it was ready set up a platform for new drug discovery techniques and put together a service team to provide technology market assessments, legal consultations and patent analyses.
To that end, the committee aims to establish three biotech science parks in different parts of the country.
Young Shuenn-Tsong (楊順聰), an adviser on the panel, said he expected the project to double biotech output within five years and stimulate private investment by at least NT$54 billion (US$167 million) each year, starting in 2013.
“The industry is expected to turn into a trillion-dollar business after 2013,” Young said in his report. “The biotech parks and industry clusters are expected to take shape in 10 years, promising further revenue potential and creating job opportunities.”
While the nation has the academic infrastructure for strengthening the biotech industry, Young said the government should help address the fact that research in the area lacks market orientation and commercial planning.
In addition, the absence of a solid supply chain between medical devices and drugs has weakened intellectual property protections and dampened profit margins, the academic said.
Academia Sinica President Wong Chi-huey (翁啟惠) agreed, saying that medical students in Taiwan were inequipped to discover new drugs, but had demonstrated the ability to do so while studying abroad. Wong expressed the hope that the panel would make better use of resources to improve the situation.
Wong said Taiwan’s share in the global biomedicine market remained small and that the nation should work harder to expand its influence.
Drug turnover picked up 1.4 percent to NT$69 billion last year, from NT$68 billion a year earlier, the Council for Economic Planning and Development said in a recent statement.
To facilitate growth, the council is establishing a Taiwan Food and Drug Administration (TFDA) that is expected to hire 500 staffers and start operations next year.
TFDA will help the industry link up with the international biomedicine market, while strengthening drug safety and oversight, Young said.
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
China has claimed a breakthrough in developing homegrown chipmaking equipment, an important step in overcoming US sanctions designed to thwart Beijing’s semiconductor goals. State-linked organizations are advised to use a new laser-based immersion lithography machine with a resolution of 65 nanometers or better, the Chinese Ministry of Industry and Information Technology (MIIT) said in an announcement this month. Although the note does not specify the supplier, the spec marks a significant step up from the previous most advanced indigenous equipment — developed by Shanghai Micro Electronics Equipment Group Co (SMEE, 上海微電子) — which stood at about 90 nanometers. MIIT’s claimed advances last
EUROPE ON HOLD: Among a flurry of announcements, Intel said it would postpone new factories in Germany and Poland, but remains committed to its US expansion Intel Corp chief executive officer Pat Gelsinger has landed Amazon.com Inc’s Amazon Web Services (AWS) as a customer for the company’s manufacturing business, potentially bringing work to new plants under construction in the US and boosting his efforts to turn around the embattled chipmaker. Intel and AWS are to coinvest in a custom semiconductor for artificial intelligence computing — what is known as a fabric chip — in a “multiyear, multibillion-dollar framework,” Intel said in a statement on Monday. The work would rely on Intel’s 18A process, an advanced chipmaking technology. Intel shares rose more than 8 percent in late trading after the
GLOBAL ECONOMY: Policymakers have a choice of a small 25 basis-point cut or a bold cut of 50 basis points, which would help the labor market, but might reignite inflation The US Federal Reserve is gearing up to announce its first interest rate cut in more than four years on Wednesday, with policymakers expected to debate how big a move to make less than two months before the US presidential election. Senior officials at the US central bank including Fed Chairman Jerome Powell have in recent weeks indicated that a rate cut is coming this month, as inflation eases toward the bank’s long-term target of two percent, and the labor market continues to cool. The Fed, which has a dual mandate from the US Congress to act independently to ensure